One of the major regulators of the intrinsic pathway is the B-cell lymphoma 2 (BCL-2) protein, which was first identified through chromosomal mapping in follicular lymphoma, where constitutive BCL-2 gene expression is driven from the immunoglobulin locus by the t(14;18) translocation [9,10]. The gene discussed is BCL2; the disease is follicular lymphoma.